BetterLife Pharma BETRF
OTC BETRF
$0.17 +0.02 (+10.39%)
As of: Oct 21, 2026 · 12:20 PM EDT

BetterLife Pharma (BETRF) Capital Expenditures (2020 - 2021)

Updated

BetterLife Pharma's Capital Expenditures came in at $16,116 for fiscal Q4 2021 (quarter ended Jan 31, 2021).

Analysis

BetterLife Pharma (BETRF) Capital Expenditures (2020 - 2021) Analysis & Trends

For FY2021 (ended Jan 31, 2021), BetterLife Pharma's Capital Expenditures was $7,595.

  • Going back by fiscal year, Capital Expenditures was -$409,788 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 2.93 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 1.32 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 322.00 Mn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 893.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 321.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 1.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 513.00 Mn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 140.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 533.00 Mn
10 BetterLife Pharma 26.26 Mn 25.52 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jan 31, 2021 16,115.78
Oct 31, 2020 52.19
API Access

BetterLife Pharma Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=BETRF&period=max&api_key=YOUR_API_KEY